Recommendation
Positive Micron is a preferred cyclical AI infrastructure exposure because HBM, DRAM pricing, and datacenter memory demand are lifting revenue, margins, and cash generation.
This test subpage implements the full stock-specific report plan for Micron: recommendation, company overview, industry position, financial analysis, valuation triangulation, thesis, risks, catalysts, and publication checks.
Micron is attractive if investors underwrite AI-driven HBM demand using normalized-cycle discipline rather than peak-cycle earnings.
Positive Micron is a preferred cyclical AI infrastructure exposure because HBM, DRAM pricing, and datacenter memory demand are lifting revenue, margins, and cash generation.
Forward earnings multiples screen inexpensive versus AI compute peers, but the right valuation method is cycle-normal EPS and FCF yield with sensitivity to DRAM/HBM pricing and capex.
Downgrade risk rises if HBM supply becomes commoditized, customer inventory builds, DRAM spot pricing rolls over, capex accelerates too quickly, or gross margin guidance deteriorates.
Micron is a memory and storage manufacturer with cyclical exposure, but AI server architectures have made high-bandwidth memory a strategic bottleneck.
| Dimension | Banking-Style Assessment | Investment Relevance |
|---|---|---|
| Business Mix | DRAM, NAND, high-bandwidth memory, SSDs, and related memory/storage products across data center, client, mobile, automotive, and embedded markets. | DRAM and HBM drive the highest strategic relevance; NAND/SSD improves with storage cycle recovery but remains more commoditized. |
| Strategic Control Point | HBM supply, advanced packaging alignment, memory density, bandwidth, power efficiency, and long-term AI customer qualification. | HBM scarcity can support premium margins and stronger customer visibility than a normal memory upcycle. |
| Customer Exposure | Cloud, AI server, PC, mobile, automotive, industrial, and enterprise storage customers. | AI datacenter customers are the key swing factor for mix, margin, and investor narrative. |
| Cycle Profile | Memory pricing remains supply-demand driven, with sharp earnings volatility across upcycles and downcycles. | The report should value Micron on mid-cycle profitability, not only the current strong earnings run rate. |
| Balance Sheet Use | Capital intensity remains high; capex discipline matters as HBM and DRAM capacity expand. | Free cash flow conversion is the proof point that separates durable AI demand from a classic capacity cycle. |
AI infrastructure demand has shifted memory from a background component to a primary constraint in accelerator platforms.
Latest reported results show a sharp profit reset, but the report should separate structural HBM mix gains from cyclical DRAM/NAND pricing recovery.
| Metric | Q2 FY2026 Result | Interpretation | Banking Report Treatment |
|---|---|---|---|
| Revenue | $8.05B | Strong revenue recovery versus prior cycle trough conditions. | Bridge growth by HBM, DRAM pricing, NAND/SSD, and end-market mix. |
| Adjusted Gross Margin | 39.7% | Material improvement as pricing and mix recover. | Stress-test normalized gross margin in base and bear cases. |
| Adjusted EPS | $1.56 | Profitability has reset upward. | Do not annualize blindly; model cycle-normal EPS and FCF. |
| Operating Cash Flow | $3.65B | High cash generation during the upcycle. | Compare operating cash flow against capex to assess true FCF durability. |
| Capex Intensity | High and strategically necessary | HBM and DRAM capacity require sustained investment. | Capex discipline is central to downside case and valuation support. |
Five-year annual history shows the full memory cycle: FY2023 trough, FY2024 recovery, and FY2025 AI-led profit reset. Figures are rounded and shown in USD billions unless noted.
FY2026E is a simple run-rate estimate calculated as FY2026 Q1 multiplied by four. It is included only for YoY comparison against FY2025 and is not management guidance. Management's official FQ2 2026 revenue outlook from the FQ1 release was $18.70B +/- $0.40B.
| Income Statement | FY2026E Q1 x 4 |
YoY vs FY2025 | FY2026 Q1 | FY2025 | YoY | FY2024 | YoY | FY2023 | YoY | FY2022 | YoY | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54.6 | +45.9% | $13.6 | $37.4 | +48.9% | $25.1 | +61.6% | $15.5 | -49.5% | $30.8 | +11.0% | $27.7 |
| Cost of revenue | $24.0 | +6.6% | $6.0 | $22.5 | +15.4% | $19.5 | +15.0% | $17.0 | +0.6% | $16.9 | -2.4% | $17.3 |
| Gross profit | $30.6 | +105.3% | $7.6 | $14.9 | +165.0% | $5.6 | +496.4% | -$1.4 | -110.2% | $13.9 | +33.3% | $10.4 |
| R&D expense | $4.7 | +23.3% | $1.2 | $3.8 | +10.7% | $3.4 | +10.1% | $3.1 | -0.1% | $3.1 | +17.0% | $2.7 |
| SG&A expense | $1.3 | +12.3% | $0.3 | $1.2 | +6.7% | $1.1 | +22.7% | $0.9 | -13.7% | $1.1 | +19.2% | $0.9 |
| Operating income | $24.5 | +150.4% | $6.1 | $9.8 | +649.2% | $1.3 | +122.7% | -$5.7 | -159.2% | $9.7 | +54.4% | $6.3 |
| Net income | $21.0 | +146.6% | $5.2 | $8.5 | +997.6% | $0.8 | +113.3% | -$5.8 | -167.1% | $8.7 | +48.2% | $5.9 |
| Diluted EPS | $18.40 | +142.4% | $4.60 | $7.59 | +984.3% | $0.70 | +113.1% | -$5.34 | -168.9% | $7.75 | +50.8% | $5.14 |
| Balance Sheet | FY2026 Q1 | QoQ vs FY2025 | FY2025 | YoY | FY2024 | YoY | FY2023 | YoY | FY2022 | YoY | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $86.0 | +3.8% | $82.8 | +19.3% | $69.4 | +8.0% | $64.3 | -3.1% | $66.3 | +12.6% | $58.8 |
| Current assets | $29.7 | +2.9% | $28.8 | +18.3% | $24.4 | +14.7% | $21.2 | -2.5% | $21.8 | +9.4% | $19.9 |
| Cash & equivalents | $9.7 | +0.9% | $9.6 | +36.9% | $7.0 | -17.9% | $8.6 | +3.8% | $8.3 | +6.4% | $7.8 |
| Inventory | $8.2 | -1.8% | $8.4 | -5.9% | $8.9 | +5.8% | $8.4 | +25.9% | $6.7 | +48.5% | $4.5 |
| Accounts receivable | $10.2 | +41.4% | $7.2 | +32.2% | $5.4 | +164.6% | $2.0 | -57.0% | $4.8 | -3.2% | $4.9 |
| Total liabilities | $27.2 | -5.1% | $28.6 | +17.9% | $24.3 | +20.6% | $20.1 | +22.9% | $16.4 | +9.8% | $14.9 |
| Long-term debt | $11.2 | -2.7% | $11.5 | +1.7% | $11.3 | -5.9% | $12.0 | +100.1% | $6.0 | +0.9% | $6.0 |
| Total equity | $58.8 | +8.6% | $54.2 | +20.0% | $45.1 | +2.3% | $44.1 | -11.6% | $49.9 | +13.6% | $43.9 |
| Free Cash Flow Calculation | FY2026E Q1 x 4 |
YoY vs FY2025 | FY2026 Q1 | FY2025 | FY2024 | FY2023 | Interpretation |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $33.6B | +92.3% | $8.4B | $17.5B | $8.5B | $1.6B | Cash generation recovered sharply as pricing and profitability improved. |
| Less: capital expenditures | ($18.0B) | +13.2% | ($4.5B) | ($15.9B) | ($8.4B) | ($7.7B) | Q1 uses management's investments in capital expenditures, net, to align with adjusted FCF. |
| Free cash flow | $15.6B | +824.6% | $3.9B | $1.7B | $0.1B | ($6.1B) | Annualized Q1 FCF implies a much stronger cash conversion year if the Q1 run rate persists. |
| FCF margin | 28.6% | +24.1 pts | 28.6% | 4.5% | 0.5% | -39.4% | FCF margin is the key test for whether AI memory demand converts into shareholder value. |
| Management Estimate / Outlook | Period | Revenue | Gross Margin | EPS | Read-Through |
|---|---|---|---|---|---|
| Reported revenue | FQ1 2026 | $13.64B | 56.0% GAAP / 56.8% non-GAAP | $4.60 GAAP / $4.78 non-GAAP | Official reported quarter used as the base for the simple annualized FY2026E run-rate calculation. |
| Simple annualized estimate | FY2026E using FQ1 x 4 | $54.57B | 56.0% GAAP run-rate | $18.40 GAAP run-rate | Mechanical estimate only; it is not management guidance and does not reflect seasonality or later-quarter guidance. |
| Management revenue guidance | FQ2 2026 outlook from FQ1 release | $18.70B +/- $0.40B | 67.0% +/- 1.0% GAAP; 68.0% +/- 1.0% non-GAAP | $8.19 +/- $0.20 GAAP; $8.42 +/- $0.20 non-GAAP | Management guidance implies acceleration from FQ1, so the Q1 x 4 estimate may be conservative if guidance is achieved. |
| Implied guidance range | FQ2 2026 outlook from FQ1 release | $18.30B to $19.10B | 66.0% to 68.0% GAAP | See above | Use this as the next forecast checkpoint when replacing the simple annualized run-rate with a full FY2026 model. |
| Financial Summary | FY2026E Q1 x 4 |
YoY vs FY2025 | FY2025 | YoY / Change | 5Y CAGR / Trend | Analyst Read-Through |
|---|---|---|---|---|---|---|
| Revenue | $54.6B | +45.9% | $37.4B | +48.9% | +11.8% 5Y CAGR | AI memory and cycle recovery drove the top-line rebound. |
| EBITDA | N/A | N/A | $18.1B | +99.5% | +15.9% 5Y CAGR | Q1 release does not provide a directly comparable EBITDA figure; update in the model after full filings are refreshed. |
| Net income | $21.0B | +146.6% | $8.5B | +997.6% | +26.0% 5Y CAGR | Profit recovery is dramatic, but must be normalized through the memory cycle. |
| Free cash flow | $15.6B | +824.6% | $1.7B | +1278.5% | +82.2% 5Y CAGR | Annualized Q1 adjusted FCF shows the potential cash-flow power if AI memory demand persists. |
| Cash vs. long-term debt | $9.7B cash / $11.2B debt | Cash +0.9%; debt -2.7% | $9.6B cash / $11.5B debt | Cash +36.9%; debt +1.7% | Cash 5Y CAGR +4.8% | Liquidity is adequate and leverage is manageable for a cyclical manufacturer. |
| Capital expenditures | $18.0B | +13.2% | $15.9B | +89.1% | +14.0% 5Y CAGR | Investment intensity is the central tradeoff behind the HBM growth thesis. |
| Financial Ratio | FY2026E / Q1 Run Rate | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | Interpretation |
|---|---|---|---|---|---|---|---|
| Gross margin | 56.0% | 39.8% | 22.4% | -9.1% | 45.2% | 37.6% | Q1 run-rate margin is well above FY2025 and supports the AI memory scarcity thesis. |
| Operating margin | 45.0% | 26.1% | 5.2% | -37.0% | 31.5% | 22.7% | Shows powerful operating leverage after the FY2023 trough. |
| Net margin | 38.4% | 22.8% | 3.1% | -37.5% | 28.2% | 21.2% | Profitability is strong but still cyclical. |
| ROE | 35.6% | 15.8% | 1.7% | -13.2% | 17.4% | 13.3% | Q1 x 4 net income creates a high return run rate, but it should be cycle-normalized. |
| ROA | 24.4% | 10.3% | 1.1% | -9.1% | 13.1% | 10.0% | Asset intensity keeps returns highly sensitive to utilization. |
| Current ratio | 2.46x | 2.52x | 2.64x | 4.46x | 2.89x | 3.10x | Liquidity remains solid despite heavy investment. |
| Debt / equity | 0.19x | 0.21x | 0.25x | 0.27x | 0.12x | 0.14x | Leverage is manageable and improved sequentially in Q1. |
| FCF margin | 28.6% | 4.5% | 0.5% | -39.4% | 10.1% | 8.8% | Q1 adjusted FCF conversion is much stronger than FY2025. |
Micron should be valued with more than one lens: trading comps for market framing, cycle-normal earnings for discipline, and DCF for HBM durability.
Compare MU to memory peers, storage peers, and broader AI semiconductor names using forward P/E, EV/EBITDA, P/FCF, and revenue growth.
Use mid-cycle DRAM and NAND margins to avoid overpaying for peak earnings or underestimating structural HBM mix gains.
Model revenue CAGR, HBM mix, gross margin, capex, working capital, WACC, and terminal multiple sensitivity.
Base, bull, and bear cases should explicitly change pricing, bit growth, capex, and exit multiple.
| Case | Operating Assumption | Valuation Assumption | Implied Stance | What To Monitor |
|---|---|---|---|---|
| Bull | HBM demand remains undersupplied, DRAM pricing holds, NAND improves, and capex supports long-term customer wins without flooding supply. | Market values MU as a strategic AI memory compounder with sustained above-cycle margins. | Positive / overweight with multiple expansion potential. | HBM backlog, gross margin guidance, AI customer qualifications, DRAM spot pricing. |
| Base | AI memory demand stays strong, but pricing normalizes gradually and capex absorbs some cash flow. | Forward multiple remains below AI compute leaders but above trough memory-cycle levels. | Positive, cycle-aware. | OCF less capex, inventory days, management supply discipline, customer concentration. |
| Bear | Supply catches up, customers digest inventory, HBM pricing normalizes faster, and NAND/DRAM margins compress. | Market reverts to memory-cycle valuation and discounts peak earnings. | Neutral or reduce exposure. | Spot pricing rollover, capex acceleration, falling book-to-bill, weaker guidance. |
The outperform case depends on AI memory scarcity translating into sustained margins, cash flow, and valuation support.
Banking readers need a forward evidence calendar that can validate or break the valuation narrative.
Track revenue guidance, HBM commentary, DRAM/NAND pricing, gross margin, capex, and inventory signals.
New or expanded HBM qualifications with leading accelerator platforms would support a higher-quality revenue mix.
Industry capex updates from Micron, Samsung, SK hynix, and NAND peers will shape cycle-normal valuation.
Operating cash flow less capex is the key test for whether the AI memory cycle becomes shareholder-value accretive.
The central risk is not that Micron lacks AI exposure; it is that investors capitalize peak memory earnings too aggressively.
| Risk | Probability | Impact | Monitoring Indicator | Mitigant / Response |
|---|---|---|---|---|
| Memory pricing reversal | Medium | High | DRAM and NAND spot prices, customer inventory, book-to-bill. | Value on mid-cycle margins and require FCF support before increasing exposure. |
| HBM competition | Medium | High | Customer qualifications, share gains/losses, pricing and capacity commentary. | Use bull-case multiple only if Micron sustains differentiated HBM position. |
| Capex overbuild | Medium | High | Capex guidance, wafer starts, capacity additions across memory suppliers. | Penalize valuation if capex rises faster than OCF and demand visibility. |
| Customer concentration | Medium | Medium | Large AI platform customer exposure and contract duration. | Track backlog quality and customer diversification by product generation. |
| Macro and PC/mobile weakness | Medium | Medium | Consumer electronics demand, OEM inventory, enterprise spending. | Separate AI/datacenter mix from weaker consumer-sensitive segments. |
| Valuation compression | Medium | Medium | Forward P/E, FCF yield, rates, and AI semiconductor sentiment. | Use downside multiple cases and avoid relying on one-year EPS alone. |
The recommended stance is positive but explicitly cycle-aware, with triggers for upgrade, maintain, or downgrade.
| Decision | Condition | Action | Rationale |
|---|---|---|---|
| Upgrade / Add | HBM demand visibility extends, gross margin guidance improves, and FCF conversion remains healthy. | Increase ranking versus cyclical peers. | Supports the view that Micron is more than a normal memory-cycle rebound. |
| Maintain | AI demand remains strong but pricing and margins begin to normalize gradually. | Hold Positive, cycle-aware stance. | Base case remains attractive if normalized earnings support valuation. |
| Downgrade | Pricing rolls over, capex accelerates, inventory builds, or HBM share/margin disappoints. | Move to Neutral. | Peak-cycle earnings would no longer justify risk-adjusted exposure. |
Before using the page as an investment memo, refresh market data and reconcile model math.
Update share price, market cap, enterprise value, net debt, diluted shares, consensus revenue, EPS, EBITDA, FCF, and forward multiples as of publication date.
Make sure comps, DCF, and cycle-normal earnings use the same share count, net debt bridge, tax assumptions, and capex framework.
Source factual claims to company releases, filings, investor presentations, or market-data pages; label forward-looking interpretation as analyst judgment.
Public information used to compile this test page. Market data must be refreshed before publication.